Followers | 145 |
Posts | 27565 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Tuesday, January 17, 2017 6:54:16 AM
Shares of Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) have received a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.
Analysts have set a 1-year consensus price target of $7.00 for the company and are forecasting that the company will post ($0.25) EPS for the current quarter, according to Zacks. Zacks has also assigned Kitov Pharmaceuticals Holdings an industry rank of 82 out of 265 based on the ratings given to its competitors.
https://sportsperspectives.com/2017/01/16/kitov-pharmaceuticals-holdings-ltd-ktov-given-7-00-consensus-price-target-by-analysts.html
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM